ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 61 - 70 of 86
Presenter(s): Samira B Anderson, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: The field of audiology focuses mostly on the peripheral auditory system-in both diagnosis and management-but other factors (e.g., "hidden hearing loss" and/or reduced cognitive ability) may play a role in an individual's ability to communicate in diverse environments. This session discusses how audiologists can incorporate evoked potential testing into the assessment battery to obtain a more comprehensive picture of auditory function.
Presenter(s): Victoria A Sanchez, AuD, PhD, CCC-A, F-AAA; Ann Clock Eddins, PhD, MBA, CCC-A, FAAA
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Emerging treatment approaches for age-related hearing loss include alternative interventions aimed at ameliorating symptoms and slowing down or even preventing hearing loss, in contrast with current treatment approaches, which focus primarily on amplification and communication strategies. This session will explore up-and-coming approaches, such as pre-clinical investigation of hormones (e.g., Aldosterone) correlated with auditory function; medicinal-related interventions; and challenges to timelines to bring new treatments to market.
Presenter(s): A.U. Bankaitis, PhD
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Medical professionals who use hearing aids can face challenges when they need to perform auscultation (listening to sounds from various organs, most often with a stethoscope) as part of their job. While the options may not seem straightforward, audiologists can play a key role in helping these medical professionals find an amplified stethoscope solution. This on demand webinar (available beginning March 21, 2024) will discuss key considerations, potential options, and practical steps for helping medical professionals with hearing loss obtain the best solution.
Presenter(s): Kimberly A Jenkins, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: In sensitive compartmented information facility (SCIF) environments, hearing aid features such as Bluetooth and bidirectional microphones—which allow seamless communication between hearing aids and communication devices—are considered security risks. This on demand webinar (available beginning March 16, 2024) will address considerations for hearing aids for patients who work in secure locations as well as share strategies currently being used by providers within the National Capital Region.
Presenter(s): Georgia Cambridge; Tracey Taylor; Wayne Wilson; Wendy Arnott
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This course presents a systematic review that aimed to answer the PICO-format clinical research question: For adults with cochlear implants and severe to profound postlingual sensorineural hearing loss, is auditory training effective in improving listening outcomes?
Presenter(s): Cynthia Hogan,PhD, CCC-A; Janalene Jacobson,AuD, CCC-A; Melanie Meldrum,AuD, CCC-A; Sarah Ostlie, AuD, CCC-A
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This course explores the most commonly fit devices for patients whose hearing is significantly poorer in one ear than the other (e.g., single-sided deafness or asymmetric hearing loss) and identify factors that impact device selection and hearing management. Using data analysis and case examples from their clinic, the speakers discuss management options for asymmetrical sensorineural hearing loss, including traditional hearing aids, Bi-CROS devices, bone conduction devices (BCD), and cochlear implants (all with or without assistive devices).This course – part of the SIGnature Series – was developed by SIG 6: Hearing and Hearing Disorders: Research and Diagnostics.
Presenter(s): Amyn M. Amlani, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The degree of hearing aid adoption as a treatment to lessen communication difficulties has remained essentially unchanged over the past four decades. This session will share evidence and hands-on tools that promote opportunities for evaluating and modifying patient readiness, with the intent of enhancing the adoption of professional audiology services and amplification technologies.
Presenter(s): Dave Fabry, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: There is no question that emerging technologies such as embedded sensors and artificial intelligence are changing the hearing health landscape. This session will look ahead to the coming decade and explore innovations in hearing health care technology, strategy, and service. The speaker will discuss practical ways to leverage these innovations to be successful in today’s and tomorrow’s dynamic market landscape.
Presenter(s): Meaghan Reed, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: It is unclear how over-the-counter hearing devices will impact our patients and our practices in the coming years. This session will discuss practical strategies for incorporating OTC devices, deciding when to offer alternative rehabilitation options to patients, and offering a wider variety of solutions to meet our patients’ needs.
Credit(s): PDHs: 3.0, ASHA CEUs*: 0.3
Summary: These three articles describe current issues and advances related to hearing diagnostics, treatment, and prevention. The first article is a detailed description of the impact that COVID-19 face masks and social distancing regulations have had on speech recognition and how face masks affect the acoustic signal and increase cognitive effort in listeners with hearing loss. Suggestions for mitigating these deleterious impacts on communication are provided. The second article is a research study examining the correlation between self-perceived hearing difficulty, determined using a questionnaire (Adult Auditory Performance Scale), and speech-in-noise performance (Listening in Spatialized Noise–Sentences Test) in listeners with normal pure-tone thresholds. Results highlight the relationship between self-perceived hearing abilities and binaural speech-in-noise performance supporting the inclusion of speech-in-noise testing even in those with normal pure-tone thresholds. The third article is a review of current genetic, stem cell, and pharmacotherapy research for treatment and prevention of hearing loss. Animal models are discussed, as well as steps to translate this research into clinical practice.
<< 1 2 3 4 5 6 7 8 9 >>